0001689375-24-000056.txt : 20240930 0001689375-24-000056.hdr.sgml : 20240930 20240930163211 ACCESSION NUMBER: 0001689375-24-000056 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240926 FILED AS OF DATE: 20240930 DATE AS OF CHANGE: 20240930 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Dowden Nathan J CENTRAL INDEX KEY: 0001873392 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40969 FILM NUMBER: 241339894 MAIL ADDRESS: STREET 1: 6 TIDE STREET CITY: BOSTON STATE: MA ZIP: 02210 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Entrada Therapeutics, Inc. CENTRAL INDEX KEY: 0001689375 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 813983399 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE DESIGN CENTER PLACE STREET 2: SUITE 17-500 CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: 857-305-1825 MAIL ADDRESS: STREET 1: ONE DESIGN CENTER PLACE STREET 2: SUITE 17-500 CITY: BOSTON STATE: MA ZIP: 02210 FORMER COMPANY: FORMER CONFORMED NAME: CycloPorters, Inc. DATE OF NAME CHANGE: 20161104 4 1 wk-form4_1727728325.xml FORM 4 X0508 4 2024-09-26 0 0001689375 Entrada Therapeutics, Inc. TRDA 0001873392 Dowden Nathan J C/O ENTRADA THERAPEUTICS, INC. ONE DESIGN CENTER PLACE, SUITE 17-500 BOSTON MA 02210 0 1 0 0 President & COO 1 Common Stock 2024-09-26 4 S 0 847 16 D 125149 D The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 8, 2024. /s/ Jared Cohen, as Attorney-in-Fact 2024-09-30